Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort

Clinical trial NCT05693766 · RECRUITING

Trial details

NCT number: NCT05693766
Sponsor: Sonya Reid
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Invasive Mammary Carcinoma Metastatic Breast Cancer

Start date: 2023-09-28
Primary completion: 2027-08-31
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.